Answers are grounded in this paper and cite their sources.
Post-transcriptional control of mRNA permeates biology, yet its contribution to sensory neuron physiology and pain remains unclear. The mammalian Pumilio proteins PUM1 and PUM2 (collectively referred to as PUM) are RNA-binding proteins that bind Pumilio response elements (PREs), typically situated in 3′ untranslated regions. PUM recruits the CCR4-NOT complex to promote mRNA deadenylation and decay. Several mRNAs that encode voltage-gated sodium channels that regulate action potential generation in pain sensing neurons harbor PREs. Here, we explored whether PUM plays a role in pain signaling. PUM1 and PUM2 were enriched in TRPV1-positive dorsal root ganglion neurons, where PUM2 physically interacted with Scn9a, Scn10a, and Scn11a transcripts, which encode Nav1.7, Nav1.8, and Nav1.9, respectively. Depletion of PUM in sensory neurons produced mechanical hypersensitivity and enhanced inflammatory pain. These effects were reversed by blocking Nav1.8 but not Nav1.7, raising the possibility that repression of Scn10a by PUM can be harnessed using synthetic biology to diminish neuropathic pain. To this end, we generated a chimera comprising the RNA-binding domain of PUM2 and a repressive domain, which we dubbed "super-PUM". Expression of AAV-encoded super-PUM in sensory neurons reduced Nav1.8 abundance, diminished tetrodotoxin-resistant and suzetrigine-sensitive sodium currents, and prevented mechanical and thermal hypersensitivity following spared nerve injury. These results demonstrate that optimization of an endogenous post-transcriptional regulon provides a means to ameliorate neuropathic pain.
No takes yet. Share an insight, caveat, or question.
García et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: